Literature DB >> 8407561

Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.

K Niwa1, T Murase, T Furui, S Morishita, H Mori, T Tanaka, H Mori, T Tamaya.   

Abstract

The present study was undertaken to examine the effects of estrogens, such as estrone (E1), 17 beta-estradiol (E2) and estriol (E3), on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea (MNU) in mice. A total of 120 female ICR mice received MNU solution (1 mg/100 g body wt.) and normal saline at 10 weeks of age into their left and right uterine corpora, respectively. One week later, they were divided into four groups and treated as follows: Group 1 (30 mice) was given 25 ppm E1-containing diet; and Group 2 (30 mice) was fed 5 ppm E2-containing diet; Group 3 (30 mice) was given 25 ppm E3-containing diet; and Group 4 (30 mice) was fed the basal diet alone. At the termination of the experiment (Week 30), all surviving animals were autopsied and histopathological examinations revealed that endometrial adenocarcinomas had developed in all groups. The incidence of adenocarcinomas in the MNU-treated uterine corpus in Group 1 (25 ppm E1-feeding, 9/23, 39%) was significantly higher than that in Group 4 (basal diet, 3/26, 12%, P < 0.05). Also, the incidences of adenocarcinomas in the MNU-treated uterine corpus in Groups 2 (5 ppm E2-feeding, 8/24, 33%) and 3 (25 ppm E3-feeding, 7/26, 28%) were higher than in Group 4, but the difference was not statistically significant. Feeding of diet containing E1, E2 and E3 increased the incidences of the preneoplastic endometrial lesions (atypical, adenomatous or cystic glandular hyperplasia). In the uterine cervix, small numbers of squamous cell carcinomas, dysplasias or hyperplasias were occasionally found in all groups. These results indicate enhancing effects of the above three types of estrogens on the endometrial carcinogenesis induced by MNU in ICR mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407561      PMCID: PMC5919289          DOI: 10.1111/j.1349-7006.1993.tb00183.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  11 in total

1.  Clinical investigations of a long-acting oestriol (polyoestriol phosphate).

Authors:  C LAURITZEN; S VELIBESE
Journal:  Acta Endocrinol (Copenh)       Date:  1961-09

2.  Effect of oestriol on the female genital tract.

Authors:  N E BORGLIN
Journal:  Acta Obstet Gynecol Scand       Date:  1959       Impact factor: 3.636

3.  Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).

Authors:  D E Englund; E D Johansson
Journal:  Br J Obstet Gynaecol       Date:  1978-12

4.  Oestrogen receptors and antagonism of steroid hormone action.

Authors:  J H Clark; E J Peck; J N Anderson
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

5.  Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer.

Authors:  P K Siiteri; B E Schwarz; P C MacDonald
Journal:  Gynecol Oncol       Date:  1974-08       Impact factor: 5.482

Review 6.  Estrone v estradiol: an examination of relative carcinogenic potential.

Authors:  M Notelovitz
Journal:  Int J Fertil       Date:  1986

7.  Spontaneous uterine adenocarcinomas in aged rats and their relation to endocrine imbalance.

Authors:  T Nagaoka; H Onodera; Y Matsushima; A Todate; M Shibutani; H Ogasawara; A Maekawa
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

8.  Effects of estriol administration on human postmenopausal endometrium.

Authors:  C Montoneri; G Zarbo; A Garofalo; S Giardinella
Journal:  Clin Exp Obstet Gynecol       Date:  1987       Impact factor: 0.146

9.  Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women.

Authors:  D E Englund; E D Johansson
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1977

10.  Rapid induction of endometrial carcinoma in ICR mice treated with N-methyl-N-nitrosourea and 17 beta-estradiol.

Authors:  K Niwa; T Tanaka; H Mori; Y Yokoyama; T Furui; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1991-12
View more
  10 in total

1.  Molecular biology of gynecological cancer.

Authors:  Kenzo Sonoda
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

2.  The role of LEF1 in endometrial gland formation and carcinogenesis.

Authors:  Dawne N Shelton; Hubert Fornalik; Traci Neff; Soo Yeun Park; David Bender; Koen DeGeest; Xiaoming Liu; Weiliang Xie; David K Meyerholz; John F Engelhardt; Michael J Goodheart
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

3.  Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice.

Authors:  K Niwa; M Hashimoto; S Morishita; Y Yokoyama; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1999-07

4.  Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.

Authors:  Z Lian; K Niwa; K Tagami; M Hashimoto; J Gao; Y Yokoyama; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  2001-07

Review 5.  Modeling Endometrial Cancer: Past, Present, and Future.

Authors:  Tom Van Nyen; Cristian P Moiola; Eva Colas; Daniela Annibali; Frédéric Amant
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

Review 6.  Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.

Authors:  Vahideh Keyvani; Espanta Riahi; Meysam Yousefi; Seyed-Alireza Esmaeili; Rana Shafabakhsh; Amin Moradi Hasan-Abad; Maryam Mahjoubin-Tehran; Michael R Hamblin; Samaneh Mollazadeh; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

7.  Involvements of Estrogen Receptor, Proliferating Cell Nuclear Antigen and p53 in Endometrial Adenocarcinoma Development in Donryu Rats.

Authors:  Midori Yoshida; Shin-Ichi Katsuda; Akihiko Maekawa
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628

8.  Inhibitory effects of medroxyprogesterone acetate on mouse endometrial carcinogenesis.

Authors:  K Niwa; S Morishita; T Murase; N Itoh; T Tanaka; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1995-08

9.  Effects of tamoxifen on endometrial carcinogenesis in mice.

Authors:  K Niwa; S Morishita; M Hashimoto; T Itoh; J Fujimoto; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1998-05

10.  Inhibitory effects of toremifene on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice.

Authors:  Kenji Niwa; Midori Hashimoto; Zenglin Lian; Jingchun Gao; Keiko Tagami; Yasuhiro Yokoyama; Hideki Mori; Teruhiko Tamaya
Journal:  Jpn J Cancer Res       Date:  2002-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.